World's First Clinical Base Edting Therapy

(Adnkronos) – CorrectSequence Therapeutics’ CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Thalassemia  SHANGHAI, Jan. 8, 2024 /PRNewswire/ — On January 8, 2024, Shanghai,China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), using innovative transformer Base Editing (tBE) technology to help people with severe